Free Shipping on purchases over €100

V.Byotic Bisglicinato De Magnesio 400 Mg , 120 comprimidos

V.Byotic Magnesium Bisglycinate 400 Mg, 120 tablets

V.Byotic magnesium bisglycinate is a potent blend of magnesium, glycine and citrate for a highly bioavailable product to optimise magnesium absorption. It also contains vitamin B6 for transport and energy support.

SKU: VB8587320027839
-13%
Promo FD
13.50
€15.47

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Magnesium bisglycinate is prepared by V.Byotic to provide athletes with a product that helps to reduce muscle recovery time. This is because it acts to relax the muscles, prevent stiffness and muscle cramps.

Similarly, it helps to relieve stress and anxiety to reduce the production of cortisol, a substance that causes oxidation of cells. It also helps to prevent premature ageing caused by this substance, and the relaxation induced by magnesium is such that it promotes restful sleep.

Magnesium is also necessary for calcium synthesis, which is why it is consumed for optimal absorption. It thus helps to prevent the formation of calcifications, as well as to strengthen bone mass, to prevent brittle bone problems and degenerative disorders of the skeletal system.

Magnesium Bisglycinate, on the other hand, has a very similar action to that of potassium, as it supports proper blood pressure levels. This is because it counteracts the effects of sodium by stimulating diuresis to relieve the pressure that retained fluid exerts on veins and arteries.

In addition, vitamin B6 has been added to support the transport of magnesium, but it also contributes to the transformation of food into energy and to strengthening the nervous system.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.